Internal Medicine, Hematology & Oncology · Grand Island, NE
NPI
1174539936
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2116 W Faidley Ave
Grand Island, NE, 68803
Phone (308) 398-5450
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.0M
274,757 services
Medicare patients, 2024
830
Average age 76
Drug cost, 2024
$4.7M
2,497 prescriptions
Company payments, 2025
$509
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ryan C Ramaekers was code J9263 (injection, oxaliplatin, 0.5 mg), 40,482 times for 21 patients. In total Ryan C Ramaekers billed 274,757 services in 162 codes, and Medicare paid $5.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 40,482 | 21 | $0.06 | $2,288 |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 39,000 | 25 | $0.87 | $34K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 27,901 | 41 | $0.11 | $3,085 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 20,802 | 21 | $44.50 | $926K |
| J1434 Injection, fosaprepitant (focinvez), 1 mg | Office | 5,100 | 13 | $2.44 | $12K |
| J0897 Injection, denosumab, 1 mg | Office | 4,320 | 16 | $20.48 | $88K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,158 | 78 | $0.09 | $374 |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 3,564 | 15 | $21.04 | $75K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 2,380 | 57 | $0.72 | $1,707 |
| 99214 Office E&M - Established | Office | 1,715 | 613 | $86.13 | $148K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 1,464 | 16 | $3.67 | $5,375 |
| 36415 Venipuncture Blood Collection | Office | 1,460 | 382 | $8.58 | $13K |
| J9190 Injection, fluorouracil, 500 mg | Office | 1,137 | 16 | $2.36 | $2,686 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 912 | 36 | $0.07 | $65.94 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 737 | 467 | $11.82 | $8,713 |
By year: 2022 $4.2M for 230,159 services; 2023 $4.2M for 216,707 services; 2024 $5.0M for 274,757 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,460 | 382 | $8.58 | $13K |
| 85025 Blood Count | 364 | 93 | $7.52 | $2,738 |
| 82565 Clinical Chemistry | 27 | 12 | $5.02 | $136 |
Medicare prescription drug claims, 2024
In 2024, the drug Ryan C Ramaekers prescribed most often to Medicare patients was Anastrozole, with 315 prescriptions and refills. In total Ryan C Ramaekers wrote 2,497 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 315 | 632 | 72 | $5,860 |
| Potassium Chloride Generic | 190 | 276 | 52 | $3,179 |
| Acyclovir Generic | 118 | 153 | 26 | $1,346 |
| Dexamethasone Generic | 116 | 139 | 67 | $2,487 |
| Ondansetron Hcl Generic | 106 | 106 | 75 | $609 |
| Prochlorperazine Maleate Generic | 95 | 95 | 72 | $966 |
| Prednisone Generic | 86 | 118 | 28 | $575 |
| Lenalidomide Generic | 71 | 71 | Under 11 | $1.0M |
| Eliquis Apixaban | 70 | 90 | 18 | $52K |
| Levothyroxine Sodium Generic | 67 | 151 | 20 | $465 |
| Omeprazole Generic | 63 | 102 | 14 | $494 |
| Hydroxyurea Generic | 56 | 105 | 14 | $1,828 |
| Letrozole Generic | 47 | 59 | Under 11 | $321 |
| Xtandi Enzalutamide | 41 | 41 | Under 11 | $539K |
| Venclexta Venetoclax | 35 | 35 | Under 11 | $218K |
Brand drugs: 398 claims; generic drugs: 2,099 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ryan C Ramaekers $509 ($509 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $74.44.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 3 | $74.44 |
| Dendreon Pharmaceuticals LLC | 1 | $58.88 |
| Daiichi Sankyo Inc. 4568.T | 2 | $50.02 |
| Pfizer Inc. PFE | 3 | $45.97 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $27.76 |
| Pharmacosmos Therapeutics Inc. | 1 | $24.62 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $22.84 |
| Aveo Pharmaceuticals, Inc. | 1 | $20 |
| BeOne Medicines USA, Inc. ONC | 1 | $18.72 |
| Astellas Pharma US Inc 4503.T | 1 | $18.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.